Lv5
840 积分 2024-09-30 加入
Personalising PARP inhibitor combinations for metastatic castration-resistant prostate cancer
1小时前
已完结
Best Practice in Preoperative Surgical Planning for Robotic-assisted Radical Prostatectomy: A European Consensus Statement
15天前
已关闭
Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trial
15天前
已完结
Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trial
27天前
已完结
Talazoparib Monotherapy in Metastatic Castration-resistant Prostate Cancer with DNA Damage Response Alterations—Genomic Features Associated with Response to Therapy
27天前
已关闭
Beyond PSMA: theranostic cell surface targets in metastatic prostate cancer
1个月前
已完结
Decision analysis of pelvic lymph node dissection during radical prostatectomy
1个月前
已关闭
Prostate cancer
1个月前
已完结
Prostate cancer
1个月前
已关闭
Prostate cancer
1个月前
已完结
皖公网安备34019202002308
